BRCA1 mutation carriers more often had a larger tumor than BRCA2 mutation carriers (pT1c 71.6% vs 63.3%, p = 0.030, data not shown) and more often had an ER-negative tumor (79.7% vs 26.4%, p < 0.001, data not shown). The gene discussed is BRCA2; the disease is neoplasm.